Updated:
Strides Pharma Science Limited
Strides Pharma Science was founded in 1990 as a pharmaceutical company based in Bangalore, India.
Strides Pharma Science Limited
Strides Pharma Science was founded in 1990 as a pharmaceutical company based in Bangalore, India. It focuses on making quality healthcare accessible worldwide. The company's portfolio spans essential generics and specialty formulations across multiple therapeutic categories. Manufacturing facilities are located in India, the US (Strides Pharma Inc, Chestnut Ridge, NY), Italy (Beltapharm S.R.L), and Kenya (Universal Corporation Limited). In Kenya, UCL became an associate company effective September 2022. The firm operates in over 100 countries, with a particular emphasis on regulated markets like the US and Europe alongside emerging markets in Africa. Strides Pharma employs a global manufacturing network and distribution platform rather than a team of investment professionals. As of March 2026, the company was reported to be stabilizing its balance sheet and shifting growth focus beyond the US (per LinkedIn news, March 2026). The company's US arm, Strides Pharma Inc., is registered in New York. The company is structured as a publicly traded operating pharmaceutical business, not a family office or investment firm. Its governance follows standard corporate and regulatory frameworks for a listed Indian company. Succession and leadership are managed through corporate board structures.
General information
Firm type
other
Year founded
1990
AUM
Undisclosed
Location
Region
Asia
Country
India
City
Bengaluru
Corporate office
KRS Gardens, No.36/7, Suragajakkanahalli, Anekal Taluk, Bengaluru – 562 106, India
Additional offices
Chestnut Ridge, NY, United States · Kikuyu Town, Kenya · Cusano ML, Italy · Chandapura, Bengaluru, India · Chennai, India · Puducherry, India
Sector focus
Frequently asked questions
Is Strides Pharma a family office or an operating company?
Strides Pharma Science Limited is a publicly listed pharmaceutical operating company, not a family office or investment manager. It manufactures and distributes generic and specialty medicines globally.
Where does Strides Pharma manufacture its medicines?
Strides operates manufacturing facilities in India (Bangalore, Chennai, Puducherry), the United States (Chestnut Ridge, NY), Italy (Cusano ML), and Kenya (Kikuyu Town). The Kenyan facility is held through an associate company effective September 2022.
What is Strides Pharma's geographic footprint?
The company has a presence in over 100 countries, including the US and European markets (Italy) as well as emerging markets in Africa. Its headquarters are in Bengaluru, India.
Who leads investment decisions at Strides Pharma?
As a publicly traded company, Strides Pharma's investment decisions are made by its board of directors and executive management. The company does not publicly disclose a named CIO or single investment decision-maker on its website.
Does Strides Pharma invest in external companies or funds?
There is no public disclosure on Strides Pharma making external investments or fund commitments. Its business is focused on pharmaceutical manufacturing and distribution.
What recent news is associated with Strides Pharma?
In March 2026, the company was reported to be stabilizing its balance sheet and shifting growth focus beyond the US, indicating a strategic pivot to markets outside the United States (per the firm's LinkedIn news, March 2026).
Is Strides Pharma involved in sustainability initiatives?
The company states it integrates environmental care, social responsibility, and governance into its operations, with eco-efficient operations and transparent reporting. Details are available on its website.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: